177 related articles for article (PubMed ID: 22951975)
1. Oncogene-dependent control of miRNA biogenesis and metastatic progression in a model of undifferentiated pleomorphic sarcoma.
Mito JK; Min HD; Ma Y; Carter JE; Brigman BE; Dodd L; Dankort D; McMahon M; Kirsch DG
J Pathol; 2013 Jan; 229(1):132-40. PubMed ID: 22951975
[TBL] [Abstract][Full Text] [Related]
2. Undifferentiated pleomorphic sarcoma with co-existence of KRAS/PIK3CA mutations.
Li B; Li L; Li X; Wang Y; Xie Y; Liu C; Li F
Int J Clin Exp Pathol; 2015; 8(7):8563-7. PubMed ID: 26339434
[TBL] [Abstract][Full Text] [Related]
3. miR-152 down-regulation is associated with MET up-regulation in leiomyosarcoma and undifferentiated pleomorphic sarcoma.
Pazzaglia L; Novello C; Conti A; Pollino S; Picci P; Benassi MS
Cell Oncol (Dordr); 2017 Feb; 40(1):77-88. PubMed ID: 27900663
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression.
Rupaimoole R; Wu SY; Pradeep S; Ivan C; Pecot CV; Gharpure KM; Nagaraja AS; Armaiz-Pena GN; McGuire M; Zand B; Dalton HJ; Filant J; Miller JB; Lu C; Sadaoui NC; Mangala LS; Taylor M; van den Beucken T; Koch E; Rodriguez-Aguayo C; Huang L; Bar-Eli M; Wouters BG; Radovich M; Ivan M; Calin GA; Zhang W; Lopez-Berestein G; Sood AK
Nat Commun; 2014 Oct; 5():5202. PubMed ID: 25351346
[TBL] [Abstract][Full Text] [Related]
5. MCPIP1 ribonuclease antagonizes dicer and terminates microRNA biogenesis through precursor microRNA degradation.
Suzuki HI; Arase M; Matsuyama H; Choi YL; Ueno T; Mano H; Sugimoto K; Miyazono K
Mol Cell; 2011 Nov; 44(3):424-36. PubMed ID: 22055188
[TBL] [Abstract][Full Text] [Related]
6. RAS/MAPK pathway hyperactivation determines poor prognosis in undifferentiated pleomorphic sarcomas.
Serrano C; Romagosa C; Hernández-Losa J; Simonetti S; Valverde C; Moliné T; Somoza R; Pérez M; Vélez R; Vergés R; Domínguez R; Carles J; Ramón Y Cajal S
Cancer; 2016 Jan; 122(1):99-107. PubMed ID: 26479291
[TBL] [Abstract][Full Text] [Related]
7. Dual Pten/Tp53 suppression promotes sarcoma progression by activating Notch signaling.
Guijarro MV; Dahiya S; Danielson LS; Segura MF; Vales-Lara FM; Menendez S; Popiolek D; Mittal K; Wei JJ; Zavadil J; Cordon-Cardo C; Pandolfi PP; Hernando E
Am J Pathol; 2013 Jun; 182(6):2015-27. PubMed ID: 23708211
[TBL] [Abstract][Full Text] [Related]
8. MDA-7/IL-24 regulates the miRNA processing enzyme DICER through downregulation of MITF.
Pradhan AK; Bhoopathi P; Talukdar S; Scheunemann D; Sarkar D; Cavenee WK; Das SK; Emdad L; Fisher PB
Proc Natl Acad Sci U S A; 2019 Mar; 116(12):5687-5692. PubMed ID: 30842276
[TBL] [Abstract][Full Text] [Related]
9. A pan-cancer atlas of somatic mutations in miRNA biogenesis genes.
Galka-Marciniak P; Urbanek-Trzeciak MO; Nawrocka PM; Kozlowski P
Nucleic Acids Res; 2021 Jan; 49(2):601-620. PubMed ID: 33406242
[TBL] [Abstract][Full Text] [Related]
10. Re-evaluation of the roles of DROSHA, Export in 5, and DICER in microRNA biogenesis.
Kim YK; Kim B; Kim VN
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):E1881-9. PubMed ID: 26976605
[TBL] [Abstract][Full Text] [Related]
11. Recurrent DICER1 hotspot mutations in endometrial tumours and their impact on microRNA biogenesis.
Chen J; Wang Y; McMonechy MK; Anglesio MS; Yang W; Senz J; Maines-Bandiera S; Rosner J; Trigo-Gonzalez G; Grace Cheng SW; Kim J; Matzuk MM; Morin GB; Huntsman DG
J Pathol; 2015 Oct; 237(2):215-25. PubMed ID: 26033159
[TBL] [Abstract][Full Text] [Related]
12. MEK1/2 inhibition elicits regression of autochthonous lung tumors induced by KRASG12D or BRAFV600E.
Trejo CL; Juan J; Vicent S; Sweet-Cordero A; McMahon M
Cancer Res; 2012 Jun; 72(12):3048-59. PubMed ID: 22511580
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA Expression Signatures Associated With BRAF-Mutated Versus KRAS-Mutated Colorectal Cancers.
Choi YW; Song YS; Lee H; Yi K; Kim YB; Suh KW; Lee D
Medicine (Baltimore); 2016 Apr; 95(15):e3321. PubMed ID: 27082577
[TBL] [Abstract][Full Text] [Related]
14. High IGF2 and FGFR3 are associated with tumour progression in undifferentiated pleomorphic sarcomas, but EGFR and FGFR3 mutations are a rare event.
Rüping K; Altendorf-Hofmann A; Chen Y; Kampmann E; Gibis S; Lindner L; Katenkamp D; Petersen I; Knösel T
J Cancer Res Clin Oncol; 2014 Aug; 140(8):1315-22. PubMed ID: 24804818
[TBL] [Abstract][Full Text] [Related]
15. In vivo structure-function analysis of human Dicer reveals directional processing of precursor miRNAs.
Gurtan AM; Lu V; Bhutkar A; Sharp PA
RNA; 2012 Jun; 18(6):1116-22. PubMed ID: 22546613
[TBL] [Abstract][Full Text] [Related]
16. Cooperation of BRAF(F595L) and mutant HRAS in histiocytic sarcoma provides new insights into oncogenic BRAF signaling.
Kordes M; Röring M; Heining C; Braun S; Hutter B; Richter D; Geörg C; Scholl C; Gröschel S; Roth W; Rosenwald A; Geissinger E; von Kalle C; Jäger D; Brors B; Weichert W; Grüllich C; Glimm H; Brummer T; Fröhling S
Leukemia; 2016 Apr; 30(4):937-46. PubMed ID: 26582644
[TBL] [Abstract][Full Text] [Related]
17. Long-term vemurafenib treatment drives inhibitor resistance through a spontaneous KRAS G12D mutation in a BRAF V600E papillary thyroid carcinoma model.
Danysh BP; Rieger EY; Sinha DK; Evers CV; Cote GJ; Cabanillas ME; Hofmann MC
Oncotarget; 2016 May; 7(21):30907-23. PubMed ID: 27127178
[TBL] [Abstract][Full Text] [Related]
18. BRAF mutation in 'sarcomas': a possible method to detect de-differentiated melanomas.
Cipriani NA; Letovanec I; Hornicek FJ; Mullen JT; Duan Z; Borger DR; Nielsen GP
Histopathology; 2014 Apr; 64(5):639-46. PubMed ID: 24117833
[TBL] [Abstract][Full Text] [Related]
19. KRAS(G12D)- and BRAF(V600E)-induced transformation of murine pancreatic epithelial cells requires MEK/ERK-stimulated IGF1R signaling.
Appleman VA; Ahronian LG; Cai J; Klimstra DS; Lewis BC
Mol Cancer Res; 2012 Sep; 10(9):1228-39. PubMed ID: 22871572
[TBL] [Abstract][Full Text] [Related]
20. Relationships among
Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
